Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
aerFree is a private U.S. medical device company focused on non-invasive airway management for adults undergoing procedures with mild to moderate sedation. Its lead and apparently sole commercial product is the aerFree Airway Management System (AMS), an FDA-cleared single-use external negative pressure airway aid designed to maintain upper-airway patency without invasive airway instrumentation. The device is positioned for use in settings such as ambulatory surgery, PACU, cath labs, MRI, colonoscopy, and other short-duration procedures where anesthesiology support may be limited. aerFree’s technology is based on the aer+ platform, which applies external negative pressure to the upper airway. The company appears to operate as a small commercial-stage medical device business rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on aerFree.